Get the Stockscreener App
1.635
0.93%
0.015
Longeveron Inc stock is traded at $1.635, with a volume of 119.40K.
It is up +0.93% in the last 24 hours and up +27.73% over the past month.
Longeveron Inc is a clinical-stage biotechnology company developing regenerative medicines to address unmet medical needs for specific aging-related and life-threatening conditions. Its investigational product is Lomecel-B an stem cell formulation sourced from the bone marrow of young, healthy adult donors and has potential mechanisms of action that can promote tissue repair and healing. The company currently has three pipeline indications: Hypoplastic Left Heart Syndrome (HLHS), Alzheimer's disease (AD) and Aging-related Frailty.
See More
Previous Close:
$1.62
Open:
$1.58
24h Volume:
119.40K
Relative Volume:
0.35
Market Cap:
$22.11M
Revenue:
$1.89M
Net Income/Loss:
$-17.92M
P/E Ratio:
-0.2444
EPS:
-6.69
Net Cash Flow:
$-15.62M
1W Performance:
-2.10%
1M Performance:
+27.73%
6M Performance:
+6.17%
1Y Performance:
-46.22%
1-Day Range:
$1.5501
$1.65
1-Week Range:
$1.54
$1.71
52-Week Range:
$1.14
$3.04
Longeveron Inc Stock (LGVN) Company Profile
Name
Longeveron Inc
Sector
Industry
Phone
305-302-7158
Address
1951 NW 7TH AVENUE, MIAMI
Compare LGVN with other stocks
| Stocks | Price | Market Cap | Revenue | Net Income | Cash Flow | EPS |
|---|---|---|---|---|---|---|
LGVN
Longeveron Inc
|
1.635 | 24.32M | 1.89M | -17.92M | -15.62M | -6.69 |
|
VRTX
Vertex Pharmaceuticals Inc
|
462.13 | 117.32B | 11.10B | -988.90M | -1.26B | -3.92 |
|
REGN
Regeneron Pharmaceuticals Inc
|
558.87 | 58.89B | 14.09B | 4.50B | 2.96B | 39.28 |
|
ALNY
Alnylam Pharmaceuticals Inc
|
401.80 | 51.14B | 2.35B | -269.70M | -75.39M | -2.09 |
|
ARGX
Argen X Se Adr
|
673.80 | 41.02B | 2.58B | 1.06B | -1.28B | 16.33 |
|
ONC
Beone Medicines Ltd Adr
|
299.01 | 32.59B | 3.81B | -644.79M | -669.77M | -6.24 |
Longeveron Inc Stock (LGVN) Upgrades & Downgrades
| Date | Action | Analyst | Rating Change |
|---|---|---|---|
| Dec-06-24 | Initiated | ROTH MKM | Buy |
Longeveron Inc Stock (LGVN) Latest News
Longeveron Inc. stock trend outlook and recovery pathHigh Conviction Screener with Trend Matching - Newser
Short interest data insights for Longeveron Inc.Ten-Year Sector Performance and Summary Analysis - Newser
Automated trading signals detected on Longeveron Inc.Daily Market Momentum Summary and Strategy - Newser
Quantitative breakdown of Longeveron Inc. recent moveStock Performance Summary Over One Year - Newser
Longeveron Inc. recovery potential after sell offReal Time Stock Movement and Alerts - Newser
What are the latest earnings results for Longeveron Inc.Swing Trade Growth Plan With High Returns - jammulinksnews.com
What makes Longeveron Inc. stock price move sharplyEntry Timing with Downside Risk Analysis - Newser
Intraday pattern recognizer results for Longeveron Inc.Smart Entry Signals for Active Traders - Newser
Real time pattern detection on Longeveron Inc. stockPredictive Screener for Daily Trade Watch - Newser
Technical signs of recovery in Longeveron Inc.Smart Chart Forecasting with AI Algorithms - Newser
New Product Launches: Will They Boost Longeveron Inc. Stock in 2025Free Weekly Return Pick Forecast Reports - Newser
Is Longeveron Inc. a Top Dividend Stock to Watch in 2025Free Pattern Alert With ROI Driven Strategy - Newser
Is now a turning point for Longeveron Inc.Consistent Profit Signals with AI Models - Newser
How does Longeveron Inc. compare to its industry peersStock Strategy Data Feed With High Returns - jammulinksnews.com
Why Longeveron Inc. stock attracts strong analyst attentionAI Driven Swing Trade Forecasting Insight - Newser
Published on: 2025-07-30 21:41:37 - Newser
Buy Signal for Longeveron Inc. Stock Key Technical Indicators to WatchFree Oversold Recovery Opportunity Stocks - Newser
Fibonacci Support Holding Strong in Longeveron Inc.Short Term Buy Zone Stock Alerts Signal Entry - metal.it
How does Longeveron Inc. generate profit in a changing economyBest Dividend Entry Points For Every Investor - jammulinksnews.com
Longeveron® Announces Licensing of New Cardiac Selective iPSC Technology for Cardiovascular Disease - BioInformant
Is it the right time to buy Longeveron Inc. stockBuild a balanced portfolio for long-term success - jammulinksnews.com
What catalysts could drive Longeveron Inc. stock higher in 2025Build wealth steadily with proven methods - jammulinksnews.com
What analysts say about Longeveron Inc. stockDynamic growth stocks - PrintWeekIndia
Is Longeveron Inc. a good long term investmentFree High-Return Strategy Alerts - PrintWeekIndia
What risks could impact Longeveron Inc. stock performanceMarket-leading capital gains - jammulinksnews.com
Longeveron Inc. Stock Analysis and ForecastFree Wealth Management Insights - Autocar Professional
Longeveron Inc Stock (LGVN) Financials Data
Revenue
Net Income
Cash Flow
EPS
Longeveron Inc Stock (LGVN) Insider Trading
| Insider Trading | Relationship | Date | Transaction | Cost | #Shares | Value ($) | #Shares Total |
|---|---|---|---|---|---|---|---|
| Soffer Rock | Director |
May 29 '25 |
Sale |
1.30 |
10,000 |
13,000 |
220,034 |
0.93%
0.15%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):